Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Miromatrix Medical Inc (MIRO)
Miromatrix Medical Inc (MIRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 32,773
  • Shares Outstanding, K 27,311
  • Annual Sales, $ 950 K
  • Annual Income, $ -29,960 K
  • 60-Month Beta 0.43
  • Price/Sales 37.07
  • Price/Cash Flow N/A
  • Price/Book 1.66
Trade MIRO with:

Options Overview Details

View History
  • Implied Volatility 371.06% ( +38.33%)
  • Historical Volatility 103.21%
  • IV Percentile 94%
  • IV Rank 55.61%
  • IV High 665.15% on 06/12/23
  • IV Low 2.71% on 10/18/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 1
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 90
  • Open Int (30-Day) 110

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate -0.18
  • Number of Estimates 1
  • High Estimate -0.18
  • Low Estimate -0.18
  • Prior Year -0.37
  • Growth Rate Est. (year over year) +51.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2000 unch
on 09/28/23
1.6699 -28.14%
on 09/15/23
-0.2200 (-15.49%)
since 08/28/23
3-Month
1.1810 +1.61%
on 08/21/23
2.0000 -40.00%
on 07/11/23
-0.5800 (-32.58%)
since 06/28/23
52-Week
0.9065 +32.38%
on 05/25/23
4.5000 -73.33%
on 11/07/22
-2.7000 (-69.23%)
since 09/28/22

Most Recent Stories

More News
Pieris Pharmaceuticals (PIRS) Reports Q1 Loss, Lags Revenue Estimates

Pieris Pharmaceuticals (PIRS) delivered earnings and revenue surprises of -28.57% and 70.24%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

PIRS : 0.3000 (+0.87%)
MIRO : 1.2000 (-7.34%)
Arcellx, Inc. (ACLX) Reports Q1 Loss, Misses Revenue Estimates

Arcellx, Inc. (ACLX) delivered earnings and revenue surprises of -123.02% and 86.17%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ACLX : 36.45 (+4.26%)
MIRO : 1.2000 (-7.34%)
CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation

CareDx, Inc. (Nasdaq: CDNA) and Miromatrix Medical Inc. (“Miromatrix”) (Nasdaq: MIRO) – today announced an exclusive partnership aimed at advancing the next wave of innovation using fully transplantable...

CDNA : 7.04 (-4.48%)
MIRO : 1.2000 (-7.34%)
Miromatrix Medical Inc. (MIRO) Reports Q4 Loss, Tops Revenue Estimates

Miromatrix Medical Inc. (MIRO) delivered earnings and revenue surprises of 10.81% and 9,200%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

MIRO : 1.2000 (-7.34%)
EXAS : 69.16 (+2.52%)
Lineage Cell (LCTX) Reports Q4 Loss, Misses Revenue Estimates

Lineage Cell (LCTX) delivered earnings and revenue surprises of 0% and 35.46%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

LCTX : 1.1700 (-1.68%)
MIRO : 1.2000 (-7.34%)
Stoke Therapeutics, Inc. (STOK) Reports Q4 Loss, Tops Revenue Estimates

Stoke Therapeutics, Inc. (STOK) delivered earnings and revenue surprises of 9.72% and 11.42%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

STOK : 3.78 (-3.08%)
MIRO : 1.2000 (-7.34%)
Heska (HSKA) Q4 Earnings and Revenues Surpass Estimates

Heska (HSKA) delivered earnings and revenue surprises of 44.74% and 3.72%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

HSKA : 119.99 (+0.04%)
MIRO : 1.2000 (-7.34%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Miromatrix Medical Inc. - MIRO

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Miromatrix Medical Inc. ("Miromatrix" or the "Company") (NASDAQ: MIRO). Such...

MIRO : 1.2000 (-7.34%)
Miromatrix and Baxter Announce Collaborative Research Agreement Aiming to Advance Care for Patients with Acute Liver Failure

Miromatrix Medical Inc. (NASDAQ: MIRO) and Baxter International Inc. (NYSE:BAX) today announced a collaborative research agreement to help support additional treatment options for patients with acute liver...

MIRO : 1.2000 (-7.34%)
BAX : 37.54 (+0.56%)
ViewRay Announces Preliminary Fourth Quarter and Full Year 2022 Results; appoints William P. "Bill" Burke as Chief Financial Officer

/PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced preliminary financial results for the fourth quarter and full fiscal year ended...

MIRO : 1.2000 (-7.34%)
AXGN : 5.06 (+1.20%)
VRAY : 0.0250 (-39.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Miromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs. The Company's initial development focus is on human livers and kidneys. Miromatrix Medical Inc. is based in EDEN PRAIRIE, Minn.

See More

Key Turning Points

3rd Resistance Point 1.3667
2nd Resistance Point 1.3333
1st Resistance Point 1.2667
Last Price 1.2000
1st Support Level 1.1667
2nd Support Level 1.1333
3rd Support Level 1.0667

See More

52-Week High 4.5000
Fibonacci 61.8% 3.1273
Fibonacci 50% 2.7032
Fibonacci 38.2% 2.2792
Last Price 1.2000
52-Week Low 0.9065

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar